Argentina positions itself as international benchmark in clinical trials

For Karina de Lazzari, president of CAOIC, the Argentine Chamber of Clinical Research Organizations, "developing clinical studies increases the reputation of the institutions and consolidates their participation in networks of the local and international scientific community".

RIO DE JANEIRO, BRAZIL - Pharmaceutical sector specialists explained why in 2021, the country broke the decade record in the number of trials and described the multiple benefits that this generates.

Some improvements introduced by the National Administration of Medicines, Food, and Medical Technology (ANMAT) added to the prestige of the Argentine medical community at the international level and promoted a significant increase in the country's overall participation in clinical trials during 2021.

Clinical trials are . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?